p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer.
Przygodzki RM, Bennett WP, Guinee DG Jr, Khan MA, Freedman A, Shields PG, Travis WD, Jett JR, Tazelaar H, Pairolero P, Trastek V, Liotta LA, Harris CC, Caporaso NE.
Przygodzki RM, et al.
Pharmacogenetics. 1998 Dec;8(6):503-11. doi: 10.1097/00008571-199812000-00007.
Pharmacogenetics. 1998.
PMID: 9918134